Clinical trial
Growth Hormone Resistance of Beta-cells in People With Impaired Fasting Glucose vs Impaired Glucose Tolerance
NCT07581860 is registered in ClinicalTrials.gov with University of Missouri-Columbia as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Growth Hormone Resistance of Beta-cells in People With Impaired Fasting Glucose vs Impaired Glucose Tolerance
- Lead sponsor
- University of Missouri-Columbia
- Phase
- Observational
- Overall status
- Not yet recruiting
- Start date
- August 1, 2026
- Completion date
- September 1, 2030
- Enrollment
- 10 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
healthy, impaired fasting glucose (ifg), impaired glucose tolerance (prediabetes), obesity & overweight